P/E ratio for Aethlon Medical (AEMD)

P/E ratio history for Aethlon Medical from 2001 to 2023

PE ratio at the end of each year

P/E ratio for similar companies or competitors

Company	P/E ratio	P/E ratio differencediff.	Country
Inovio Pharmaceuticals INO	-6.48	6,943.87%	🇺🇸 USA
Coherent COHR	-34.3	37,219.47%	🇺🇸 USA
Bruker BRKR	27.2	-29,628.82%	🇺🇸 USA
Pacific Biosciences PACB	-1.48	1,509.89%	🇺🇸 USA
Accelerate Diagnostics AXDX	-0.2136	132.31%	🇺🇸 USA
PerkinElmer PKI	15.0	-16,376.68%	🇺🇸 USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.